BI-2081 |
BI-2081 : Agonist of FFAR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FFAR1 |
|
|
Agonist
extracellular target
up to 200 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Eurofins Safety Panel (44 GPCRs at 10 μM): Closest off-targets (Kd [µM]): ADRA2C (0.840), ADRA2A (1. ...
Potency Cellular
In Vitro
FFAR1
Mode of Action: Agonist
Structure-Activity-Relationship data available? No
Other Reference: Peer reviewed at SGC
In Vivo Validations
Rat
Dose: 1 mg/Kg IV, 10 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
6.9% QH
Tmax:
1.17 h
Bioavailability:
79%
Volume of Distribution at Steady-State:
0.9 L/Kg
Other Reference: Peer reviewed at SGC
Negative Control Compounds
CANSAR3894697
Notes: BI-0340: EC50 = 1230 nM (human IPOne assay); Eurofins Safety Panel 44™: clean (closest off-target: NR3C1 (57 % inh. at 10 µM))
Chemical Information
| Molecular Formula | C32H35FO6 |
| SMILEs | Cc1cc(OCCC(C)(C)O)cc(C)c1-c1ccc(F)c2c1CC[C@H]2Oc1ccc2c(c1)OC[C@H]2CC(=O)O |
| InChI | InChI=1S/C32H35FO6/c1-18-13-22(37-12-11-32(3,4)36)14-19(2)30(18)24-7-9-26(33)31-25(24)8-10-27(31)39-21-5-6-23-20(15-29(34)35)17-38-28(23)16-21/h5-7,9,13-14,16,20,27,36H,8,10-12,15,17H2,1-4H3,(H,34,35)/t20-,27-/m1/s1 |
| Molecular weight | 534.24 Da |
| AlogP | 0.0 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 74 |